Avadel Pharmaceuticals (AVDL) Debt Ratio: 2009-2022
Historic Debt Ratio for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Sep 2022 value amounting to 0.93.
- Avadel Pharmaceuticals' Debt Ratio rose 73.72% to 0.93 in Q3 2022 from the same period last year, while for Sep 2022 it was 0.93, marking a year-over-year increase of 73.72%. This contributed to the annual value of 0.58 for FY2021, which is 39.98% up from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Debt Ratio of 0.93 as of Q3 2022, which was up 9.90% from 0.85 recorded in Q2 2022.
- Over the past 5 years, Avadel Pharmaceuticals' Debt Ratio peaked at 0.93 during Q3 2022, and registered a low of 0.01 during Q2 2020.
- Moreover, its 3-year median value for Debt Ratio was 0.50 (2021), whereas its average is 0.49.
- Per our database at Business Quant, Avadel Pharmaceuticals' Debt Ratio crashed by 96.17% in 2020 and then spiked by 8,848.72% in 2021.
- Quarterly analysis of 5 years shows Avadel Pharmaceuticals' Debt Ratio stood at 0.66 in 2018, then increased by 27.74% to 0.84 in 2019, then slumped by 51.04% to 0.41 in 2020, then surged by 39.98% to 0.58 in 2021, then spiked by 73.72% to 0.93 in 2022.
- Its Debt Ratio was 0.93 in Q3 2022, compared to 0.85 in Q2 2022 and 0.65 in Q1 2022.